Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate Invivyd, Inc. before investing.

In this article, we go over a few key elements for understanding Invivyd, Inc.’s stock price such as:

• Invivyd, Inc.’s current stock price and volume
• Why Invivyd, Inc.’s stock price changed recently
• Upgrades and downgrades for IVVD from analysts
• IVVD’s stock price momentum as measured by its relative strength

About Invivyd, Inc. (IVVD)

Before we jump into Invivyd, Inc.’s stock price, history, target price and what caused it to recently rise, let’s take a look at some background.

Invivyd, Inc., together with its subsidiaries, engages in the research, development, commercialization, and sale of antibody therapies for the prevention and treatment of viral infectious diseases in the United States. The company offers Pemivibart, a half-life extended investigational monoclonal antibody for the pre-exposure prophylaxis prevention of COVID-19 in adults and adolescents through injection under the PEMGARDA brand. It also develops VYD2311, a monoclonal antibody, which is in Phase III clinical trial for the prevention and treatment of SARS-CoV-2 virus; and VBY329, a monoclonal antibody, which is in pre-clinical trial stage for the prevention and treatment of respiratory syncytial virus and measles in neonates, infants, and children. It has a collaboration agreement with Adimab, LLC for the discovery and optimization of proprietary antibodies. The company was formerly known as Adagio Therapeutics, Inc. and changed its name to Invivyd, Inc. in September 2022. Invivyd, Inc. was incorporated in 2020 and is headquartered in New Haven, Connecticut.

Want to learn more about Invivyd, Inc.’s stock? Click the button below to subscribe to A+ Investor and get access to everything you need to know about Invivyd, Inc..

Invivyd, Inc.’s Stock Price as of Market Close

As of August 06, 2026, 4:00 PM, CST, Invivyd, Inc.’s stock price was $0.659.

Invivyd, Inc. is up 9.03% from its previous closing price of $0.604.

During the last market session, Invivyd, Inc.’s stock traded between $0.609 and $0.670. Currently, there are approximately 309.67 million shares outstanding for Invivyd, Inc..

Invivyd, Inc.’s trailing earnings per share are negative, so the stock does not have a meaningful P/E ratio. We suggest investors evaluate other financial metrics to understand its overall valuation.

Invivyd, Inc. Stock Price History

Invivyd, Inc.’s (IVVD) price is currently up 23.18% so far this month.

During the month of August, Invivyd, Inc.’s stock price has reached a high of $0.670 and a low of $0.545.

Over the last year, Invivyd, Inc. has hit prices as high as $3.070 and as low as $0.483. Year to date, Invivyd, Inc.’s stock is down 73.32%.

Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions

What Caused Invivyd, Inc. Stock’s Price to Rise?

Stock prices are primarily based on seller supply and buyer demand. But have you ever wondered about what other factors affect a stock's price?

When an analyst changes their opinion of a stock by upgrading or downgrading their rating, it often leads to a sudden stock price adjustment. As of August 05, 2026, there were 2 analysts who downgraded Invivyd, Inc.’s stock and 1 analyst who upgraded over the last month.

Additionally, you'll want to evaluate Invivyd, Inc.’s financial health and valuation. Investors can use AAII's Value Grade, which combines six key valuation metrics like P/E and P/S ratios for a comprehensive analysis to conduct analysis on Invivyd, Inc.’s valuation and financial health. This approach mitigates the limitations of single-metric evaluations.

Invivyd, Inc.’s current valuation based on AAII’s Value Grade is a D, which means it is considered to be Expensive.

Learn how to evaluate stocks with AAII Grades and Scores with A+ Investor today.

Lastly, news and media coverage as well as recent press reports about the company or its industry may cause stock prices to fluctuate. You can check out the most recent news articles about Invivyd, Inc. (IVVD) by visiting AAII Stock Evaluator.

Relative Price Strength of Invivyd, Inc.

Relative price strength measures a stock's performance against the market, helping investors identify stocks that are outperforming benchmarks.

For AAII’s Momentum Grade, a weighted relative price strength is calculated. Follow this link to learn more about the Momentum Grade.

As of August 05, 2026, Invivyd, Inc. has a weighted four-quarter relative price strength of -5.74%, which translates to a Momentum Score of 35 and is considered to be Weak.

Want to learn more about how Invivyd, Inc. is graded based on AAII’s composite scores for value, growth, quality and earnings estimate revisions? Subscribe to A+ Investor today.

Invivyd, Inc. Stock Price: Bottom Line

As of August 6, 2026, Invivyd, Inc.’s stock price is $0.659, which is up 9.03% from its previous closing price.

AAII advises against making stock decisions based solely on price or past returns. Instead, consider a variety of metrics, fundamentals, and analytics to evaluate a stock like Invivyd, Inc. stock prices are influenced by market supply and demand and offer just a snapshot of a company's overall health.

Subscribing to AAII's A+ Investor provides access to comprehensive analytics and insights for confident investing.